As of today, Pentixapharm Holding AG (ISIN: DE000A40AEG0) is listed in the Prime Standard of the Frankfurt Stock Exchange. The initial price of the share was EUR 5.10. The current share price is available via Börse Frankfurt.
The IPO was accompanied by BankM as Global Coordinator and Bookrunner, as well as designated sponsor on Xetra. The specialist on the trading venue Börse Frankfurt is Wolfgang Steubing.
Pentixapharm Holding AG was founded in 2024 to incorporate all shares held in Pentixapharm AG as part of the spin-off from its parent company Eckert & Ziegler SE. Founded in Würzburg in 2019, Pentixapharm is a biopharmaceutical company that manufactures radiopharmaceuticals for the diagnosis and therapy of various diseases, primarily cancer and inflammatory diseases.
